FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

19534811000001100: Lactulose 3.1-3.7g/5ml oral solution (Almus Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Oct 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
66167701000001117 Lactulose 3.1-3.7g/5ml oral solution (Almus Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
66167801000001114 Lactulose 3.1-3.7g/5ml oral solution (Almus Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lactulose 3.1-3.7g/5ml oral solution (Almus Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lactulose 3.1-3.7g/5ml oral solution (Almus Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lactulose 3.1-3.7g/5ml oral solution (Almus Pharmaceuticals Ltd) Is a Product containing precisely lactulose 670 milligram/1 milliliter conventional release oral solution true Inferred relationship Existential restriction modifier
Lactulose 3.1-3.7g/5ml oral solution (Almus Pharmaceuticals Ltd) Has active ingredient Lactulose false Inferred relationship Existential restriction modifier
Lactulose 3.1-3.7g/5ml oral solution (Almus Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Lactulose 3.1-3.7g/5ml oral solution (Almus Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lactulose 3.1-3.7g/5ml oral solution (Almus Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lactulose 3.1-3.7g/5ml oral solution (Almus Pharmaceuticals Ltd) Has specific active ingredient Lactulose true Inferred relationship Existential restriction modifier
Lactulose 3.1-3.7g/5ml oral solution (Almus Pharmaceuticals Ltd) Has dispensed dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Lactulose 3.1-3.7g/5ml oral solution (Almus Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lactulose 3.1-3.7g/5ml oral solution (Almus Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Lactulose 3.1-3.7g/5ml oral solution (Almus Pharmaceuticals Ltd) 300 ml Has AMP True Lactulose 3.1-3.7g/5ml oral solution (Almus Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Lactulose 3.1-3.7g/5ml oral solution (Almus Pharmaceuticals Ltd) 500 ml Has AMP True Lactulose 3.1-3.7g/5ml oral solution (Almus Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start